Does Sermorelin Work? What the Human Studies Actually Show, How Long It Takes, and What Results Are Realistic
Does sermorelin work? Yes, for its clearest measured effect: stimulating the pituitary to release more growth hormone. Everything after that is less certain. Small studies in older adults found mixed IGF-1 and body-composition results, no reliable weight loss, and no clear sleep benefit. It does not treat low testosterone.
So the honest answer has two halves. Sermorelin can move the growth-hormone system. It has not been shown to reliably deliver every result it is sold for.
That gap is what this page is about. We read the human studies we could verify, wrote down exactly which molecule each one tested and on whom, and lined up what changed against what did not. There is also a detail almost nobody selling sermorelin mentions: the most-quoted adult “sermorelin” trial did not test plain sermorelin at all. We will get to that.
Who the adult evidence actually resembles
Closest match to the adult research: healthy adults mostly in their mid-50s through 70s, often with lower age-related GH/IGF-1 activity. That is not the same as proving that an adult with a low-for-age IGF-1 should take sermorelin.
Poor fit for what the evidence supports:
- Weight loss is your main goal. Sermorelin has not been shown to cause meaningful weight loss.
- You want fast or dramatic changes. No controlled study showed that.
- You compete in tested sports. Sermorelin is listed by the World Anti-Doping Agency as a prohibited growth-hormone-releasing factor.
- You think fatigue, low libido, or muscle loss automatically means you need sermorelin. Those symptoms have many causes and do not identify a growth-hormone problem.
- You may have true growth hormone deficiency or pituitary disease. That belongs with an endocrinologist and proper diagnostic testing.
TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.
What does sermorelin actually do in your body?
Sermorelin is the 29-amino-acid fragment of growth hormone-releasing hormone, or GHRH, that can stimulate the pituitary gland to release growth hormone. It does not supply growth hormone directly. Growth hormone can then stimulate production of IGF-1, a downstream hormone that is commonly measured in blood.
Think of it as a three-step chain:
- Sermorelin reaches GHRH receptors in the pituitary.
- The pituitary releases growth hormone. Human studies of GHRH(1-29) showed a clear GH response.
- Growth hormone can raise IGF-1. IGF-1 is more stable in blood than the short pulses of growth hormone and is often used as one part of evaluating the GH axis.
Here is the catch that shapes everything below. Each step is a different outcome. A growth-hormone pulse does not guarantee a higher IGF-1 level. A higher IGF-1 level does not guarantee more muscle, less fat, better sleep, more energy, or better health.
A lot of sermorelin marketing jumps from step 1 straight to “you will look and feel younger.” The studies do not make that jump.
Two more things matter:
- Sermorelin is short-acting. The GHRH research used repeated injections because the signal does not stay elevated all day.
- A pituitary response is not a diagnosis. If true adult growth hormone deficiency is suspected, Endocrine Society guidance recommends formal GH stimulation testing in the right clinical setting; a single GH level is not enough.
What do the studies on sermorelin actually show?
The human evidence is real but small. Geref was studied in children with growth hormone deficiency, while the adult evidence mostly comes from small studies of GHRH(1-29) in healthy older adults. Those studies consistently showed a GH response, but IGF-1, body composition, strength, sleep, and other downstream outcomes were mixed.
This is the table we wished existed when we started. Each row shows what was actually tested. The molecule column matters more than it looks.
The Sermorelin Evidence Ledger
What this adds up to
- The GH response is the most consistent finding.
- IGF-1 is less consistent. It rose in some studies and did not rise in the six-week nightly GHRH(1-29) study.
- Body changes, when seen, were modest and took months.
- Strength and physical function did not improve consistently.
- Sleep did not improve in the longer UW/VA research program.
- The studies do not match the typical modern commercial buyer very well. Most adult participants were older, sample sizes were small, and the studies did not test today's compounded products as sold by current telehealth clinics.
The detail almost nobody mentions
The adult trial you will often see quoted for lean mass, libido, well-being, and skin changes is Khorram 1997.
It did not test plain sermorelin.
It tested [Nle27]GHRH(1-29)-NH2, a modified GHRH analog with a different amino acid at position 27. It is closely related to sermorelin, but it is not the same molecule.
That does not make the study useless. It means the result has to be labeled honestly.
The studies that did use GHRH(1-29) in older adults found a clear GH response, mixed IGF-1 results, and either limited or no short-term body-composition changes. That is not a scandal. It is the actual state of the evidence, and you deserve to know it before you pay.
Here is the one hard truth, and why it matters
Sermorelin does not have a modern, large controlled trial in people who look like most commercial buyers today.
If proven body recomposition, better sleep, weight loss, or a large visible change is your top priority, the evidence is too thin to promise it.
If your symptoms make you wonder about testosterone deficiency, that is a different diagnostic question. If true growth hormone deficiency or pituitary disease is possible, an endocrinologist is the better starting point.
How long does sermorelin take to work?
Growth hormone can respond quickly, but that is not the same as a result you can feel or see. In human research, IGF-1 changed within about two weeks in one twice-daily study, did not change after six weeks in another nightly study, and body-composition changes—when they appeared—were measured over roughly four to six months.
The realistic sermorelin timeline
Why every seller's timeline sounds the same
If you have read a few sermorelin sites, you have probably seen the pattern: better sleep first, energy next, body changes later.
It sounds like a clinical course. It often is not one.
A September 2026 audit by SermorelinReport reviewed 88 sermorelin seller pages. Fifteen published a visible results timeline. Only five of the 88 cited research somewhere on the page. The audit found that sellers commonly repeated similar week-by-week claims even though the controlled evidence did not establish a dependable universal timeline.
That matches the biggest problem in the studies: the earliest hormone change and the outcome you actually care about are not the same thing.
“I am four weeks in and feel nothing. Is it broken?”
The studies cannot answer that for an individual.
Feeling different is subjective. IGF-1 is only one lab marker. Body composition is another outcome. Sleep is another. None can stand in for all the others.
If you are already under a clinician's care, ask what outcome they are monitoring, when they plan to reassess it, and what would make them continue, change, or stop the plan. That gives you a real decision rule instead of a seller's generic timeline.
One more thing worth checking early: your billing cycle. If a program renews before the outcome you care about could reasonably be reassessed, know the cancellation and refund terms before the next charge.
What are the real benefits of sermorelin?
The clearest demonstrated effect is increased growth-hormone release. Human studies also produced limited signals for higher IGF-1, lean mass, body fat, skin thickness, well-being, libido, and some cognitive measures, but those findings were small, inconsistent, sex-specific, or based on a related analog. Weight loss, reliable strength gains, better sleep, and anti-aging outcomes were not established.
Here is every common claim graded against the Evidence Ledger above.
- Shown: found directly in the human evidence and reasonably repeatable
- Small signal: found in a small study or program, but not consistently enough to promise
- Not shown: measured and not clearly improved
- No direct evidence: not established by a human sermorelin/GHRH(1-29) trial for that outcome
Sermorelin claims vs. what the studies found
Does sermorelin build muscle?
Not reliably.
Lean body mass increased in some older men, but lean mass includes water and other non-fat tissue. The six-week GHRH(1-29) study found no DEXA change in muscle or fat, and the related full-length GHRH study did not improve leg strength.
If muscle and strength are your goal, resistance training has a much stronger evidence base than sermorelin.
Does sermorelin help you lose weight or burn belly fat?
Weight loss: not shown.
Body weight did not meaningfully change in the trials reviewed.
Body fat: limited signal.
The UW/VA program reported an average 5–8% reduction in body fat, with an important abdominal component, after about six months of GHRH treatment in healthy older adults. Other studies found no short-term fat change.
That is not enough to describe sermorelin as a weight-loss treatment.
Does sermorelin help you sleep better?
This is one of the most common marketing claims, and it is one of the weakest parts of the evidence.
The UW/VA research program reported that sleep quality did not improve. The researchers suggested that the short duration of the GHRH signal might help explain the lack of sleep benefit.
If sleep is the main problem, evaluate sleep as its own problem. Loud snoring, witnessed pauses in breathing, and severe daytime sleepiness can point to sleep apnea and deserve proper clinical evaluation.
Does sermorelin slow aging?
No GH-raising therapy is approved to treat normal aging.
The Endocrine Society's 2023 scientific statement says no therapy that increases GH secretion or action is approved as an anti-aging intervention and notes that the risks may outweigh the benefits.
That is different from saying a hormone marker can never change. It means changing the marker has not been shown to reverse aging or extend life.
Your goal decides whether sermorelin even makes sense. If you are not sure whether your symptoms point to testosterone, sleep, thyroid, pituitary disease, weight-related issues, or something else, start by sorting out the care route instead of choosing a peptide first.
TRT Provider Guide's Find My TRT Path tool is educational and non-diagnostic. It helps you map your situation to the questions and care route worth discussing before you pay.
Map the care route that fits your situation →
The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.
Does sermorelin increase testosterone?
There is no good evidence that sermorelin raises testosterone. It acts on the growth-hormone axis, while testosterone is controlled by a different hormone system. Symptoms such as low libido, fewer spontaneous erections, low energy, or loss of muscle can occur with testosterone deficiency, but symptoms alone do not diagnose it.
It is easy to see why people mix the two up. Both are marketed to men with overlapping promises around energy, body composition, libido, and “feeling like yourself again.”
They are not the same treatment.
Low testosterone cannot be diagnosed from symptoms alone or one lab result. Current Endocrine Society guidance requires symptoms or signs plus consistently low testosterone, confirmed with repeat morning testing using appropriate assays.
Read two low testosterone tests before TRT and what testosterone level qualifies for TRT for the full testing framework.
Can you take sermorelin with TRT? Some clinics offer both, but evidence that adding sermorelin to TRT improves patient-important outcomes is limited. That decision belongs with the clinician managing the full plan.
For the full side-by-side, read sermorelin vs TRT.
Affiliate disclosure: TRT Provider Guide may earn compensation if you use certain links and complete a qualifying action. We do not charge you for using our links. Compensation does not determine our factual findings, evidence summaries, or editorial conclusions. How We Review TRT Providers.
Does this sound more like a testosterone question than a growth-hormone question? If low libido, fewer morning erections, low energy, and loss of muscle are the reason you started reading about sermorelin, the next step is proper testosterone evaluation—not assuming sermorelin is the answer.
Review Male Excel's current eligibility, testing, state access, and costs before paying →
Male Excel is an active TRT Provider Guide affiliate relationship as disclosed by the site. Its own evaluation and prescribing process still requires clinician review; a test result or intake does not guarantee treatment.
Not ready to compare providers? Read sermorelin vs TRT first.
Is sermorelin FDA-approved and legal in 2026?
No currently marketed FDA-approved sermorelin product exists in the United States. Geref, a sermorelin acetate product, was historically FDA-approved for a pituitary diagnostic use and later for certain children with growth hormone deficiency. FDA withdrew the approvals in 2009 after the manufacturer discontinued the products, then determined in 2013 that the withdrawal was not for safety or effectiveness reasons.
Here is the short history:
- December 28, 1990: FDA approved Geref under NDA 19-863 for diagnostic evaluation of pituitary growth-hormone release.
- September 26, 1997: FDA approved Geref under NDA 20-443 for idiopathic or organic growth-hormone deficiency in children with growth failure.
- 2008: EMD Serono notified FDA that it was discontinuing the Geref products and requested withdrawal of the approvals.
- June 18, 2009: withdrawal of the Geref approvals became effective.
- March 4, 2013: FDA published its determination that Geref had not been withdrawn for reasons of safety or effectiveness.
Those historical approvals do not make a compounded sermorelin product FDA-approved. Geref was not approved for adult anti-aging, fat loss, muscle gain, sleep, recovery, or longevity.
What “compounded” means for you
Compounded drugs are not FDA-approved finished drug products. FDA does not review them for safety, effectiveness, and manufacturing quality in the same way it reviews an approved drug.
The legal pathway for compounding also matters. Sections 503A and 503B of federal law place limits on which bulk drug substances may be used, and those lists and policies change over time. FDA's current compounding materials should be checked when a pharmacy or provider claims a particular sermorelin product is lawfully compounded.
Practical questions to ask:
- Which pharmacy will dispense the medication?
- Is that pharmacy licensed to dispense to your state?
- What exact dosage form is being prescribed?
- Is the provider making a claim about FDA approval that applies only to historical Geref?
- What monitoring, follow-up, cancellation, and refund terms apply before the first renewal?
“Sermorelin used to have an FDA-approved product” is not the same claim as “this compounded product is FDA-approved.”
Avoid “research peptide” sellers
A product sold as “for research only” is not a substitute for a prescribed medication from a lawful clinical and pharmacy pathway. Do not treat a certificate of analysis or a website purity claim as FDA approval or as proof that a product is appropriate for human use.
Why sermorelin is different from CJC-1295 and ipamorelin
Sermorelin has a real FDA approval history through Geref. CJC-1295 and ipamorelin do not share that approval history.
But historical approval does not automatically validate today's compounded sermorelin product, dose, delivery form, or adult use. Each claim has to stand on its own evidence and current regulatory basis.
For tested athletes
The 2026 World Anti-Doping Agency Prohibited List names sermorelin under growth-hormone-releasing factors in section S2.2.4. That category is prohibited at all times, in and out of competition.
If anti-doping rules apply to you, check the current WADA rules and your sport's therapeutic-use-exemption process before using any prohibited substance.
What are the side effects of sermorelin, and who should be careful?
There is no current FDA-approved sermorelin label for today's compounded adult products, so side-effect claims should not be presented as if a modern approved label exists. Historical Geref information and older studies reported injection-site reactions and other short-term effects, while the modern long-term safety of compounded sermorelin for adult wellness or anti-aging use is not well established.
The older clinical literature and historical product experience most often describe effects such as:
- Injection-site pain, redness, or swelling
- Flushing
- Headache
- Dizziness
- Nausea
Those are useful signals, not a guarantee of what a current compounded product will do.
The GH/IGF-1 system also interacts with glucose metabolism. If you have diabetes, abnormal glucose control, pituitary disease, a history of cancer, thyroid disease, are pregnant, or take other hormone-related medicines, that is a reason to discuss the full history with a clinician before treatment rather than relying on a generic peptide checklist.
Seek urgent medical care for severe allergic symptoms, trouble breathing, fainting, chest pain, or another serious or rapidly worsening reaction.
For a deeper evidence review, see sermorelin side effects.
What does a real sermorelin “before and after” look like?
A photo can show that someone's appearance changed. It cannot show that sermorelin caused the change. The more useful before-and-after is a preselected set of measurements tied to the outcome you and your clinician are actually trying to change.
Why before-and-after photos prove so little
Diet, training, weight-loss treatment, testosterone, sleep changes, lighting, hydration, posture, a workout “pump,” and photo selection can all change what a person looks like.
The adult studies did not use transformation photos as their key outcome. They measured things such as hormones, body composition, weight, strength, cognition, and sleep.
Before you trust a sermorelin transformation, ask five questions:
- Was sermorelin the only meaningful thing that changed?
- Was the result measured, or just photographed?
- Did diet, training, weight-loss treatment, or testosterone change at the same time?
- Were the photos taken under comparable conditions?
- Are you seeing a typical result, or the best result selected for marketing?
If those answers are missing, the photo cannot tell you how much of the change came from sermorelin.
The Sermorelin Results Tracker
This is a framework for a clinician discussion, not a prescription or a lab-interpretation tool.
How to read an IGF-1 change
Do not use an IGF-1 change as a personal pass/fail rule.
Age-adjusted reference ranges matter. The reason for treatment matters. The assay matters. Other health conditions matter.
A higher IGF-1 can show that the downstream hormone changed. It still does not prove that the result you are paying for—better sleep, less fat, more strength, or better health—improved.
Questions to ask before you pay
- What exact problem are we treating?
- What evidence supports sermorelin for that problem?
- Which pharmacy will dispense it?
- What exact treatment format is being offered?
- Which baseline and follow-up labs are part of my care, and which cost extra?
- What outcome will we use to decide whether continuing makes sense?
- What is the complete six-month cost, including membership, medication, labs, visits, supplies, and shipping?
- When does billing renew?
- What is the cancellation and refund policy?
- What happens if the expected clinical outcome does not improve?
Is sermorelin worth it?
It may be worth discussing when a clinician has a clear reason for using it, the goal is measurable, and you understand how limited the adult evidence is. It is a weak fit if your main goal is weight loss, fast muscle gain, better sleep, or treatment of low testosterone—and suspected true growth hormone deficiency belongs with endocrinology.
Find your main goal in this table:
What it really costs
The advertised drug price is not the whole cost.
A useful comparison includes:
- Intake or consultation
- Membership
- Medication
- Baseline labs
- Follow-up labs
- Supplies
- Shipping
- Renewal timing
- Minimum commitment
- Cancellation terms
- Refund policy
We do the seller-by-seller math in sermorelin cost.
The better rule is not “budget for six months because you must stay on it.” The better rule is:
Know the total cost through your planned reassessment point before the first payment.
That keeps the clinical decision and the billing decision on the same timeline.
How does sermorelin compare with HGH, CJC-1295, ipamorelin, tesamorelin, and tablets?
These are not interchangeable. Somatropin is FDA-approved for defined growth-hormone-deficiency indications, tesamorelin is FDA-approved for a specific HIV-related abdominal-fat indication, and neither CJC-1295 nor ipamorelin is an FDA-approved drug. Modern compounded sermorelin products are also not FDA-approved finished drugs. Evidence from one molecule or delivery form cannot simply be transferred to another.
A 2007 systematic review of GH treatment in healthy older adults found modest changes in lean and fat mass but more adverse effects and no basis for recommending GH as an anti-aging therapy.
That is a useful ceiling for expectations: even directly giving growth hormone is not the same as proving better strength, function, sleep, longevity, or quality of life in healthy aging.
For the delivery-form question, see sermorelin tablets vs injections.
Sermorelin study claims we could not verify
Some sermorelin pages repeat precise study numbers that do not match the primary studies we could identify. A specific number should come with a study you can open and check. These were claims we could not substantiate against the primary literature and official records we reviewed as of October 2026.
Found something we got wrong? Use our corrections process and give us the source. We will check it.
How we researched this page
We read primary human studies, FDA records, current FDA compounding material, specialty-society guidance, and current WADA rules. We separated plain GHRH(1-29) evidence from modified GHRH analogs and full-length GHRH, and we separated a hormone response from outcomes such as fat, muscle, sleep, weight, and function.
We follow How We Review TRT Providers, which keeps four kinds of claims apart:
- Verified fact: checked against a primary source or authoritative record
- Provider-stated fact: what a provider says about itself, labeled as such
- Customer-experience signal: attributable reports that can describe service but cannot prove a drug works
- Editorial judgment: our conclusion built from the verified facts above
What we actually verified (October 2026)
Primary and authoritative sources checked:
- Corpas et al. 1992, GHRH(1-29) in older men
- Vittone et al. 1997, nightly GHRH(1-29) in healthy older men
- Khorram et al. 1997, [Nle27]GHRH(1-29)-NH2
- Merriam et al. 2001 review of two 6-month GHRH studies in normal aging
- Geref pediatric study and FDA approval records
- FDA's 2013 Federal Register determination on Geref
- FDA's current bulk-drug-substance compounding framework
- Endocrine Society scientific statement on hormones and aging
- Endocrine Society guidance for adult GH deficiency and testosterone deficiency
- 2026 World Anti-Doping Agency Prohibited List
- Liu et al. 2007 systematic review of GH in healthy older adults
Facts confirmed: Geref's approval and withdrawal history; FDA's finding that Geref was not withdrawn for safety or effectiveness reasons; the adult studies' populations and major measured outcomes; the modified molecule used in Khorram 1997; the UW/VA program's average IGF-1 and body-composition findings; lack of improved sleep in that program; the Endocrine Society's position on GH-raising anti-aging therapy; and WADA's explicit listing of sermorelin.
Commercial status confirmed: TRT Provider Guide's own affiliate disclosure currently names Male Excel's TRT offer and Hone Health's TRT/ED offers as affiliate relationships. We did not find a published site disclosure establishing a paid sermorelin-specific Hone affiliate relationship, so this page does not include a paid Hone sermorelin referral link.
What remains uncertain: long-term adult outcomes beyond the small older studies; whether today's compounded formulations produce the same outcomes; whether oral or troche formulations produce clinically meaningful effects; and the right individual monitoring schedule for a person prescribed sermorelin.
This page has not been clinically reviewed. It is educational information written by our editorial team, not medical advice.
Frequently asked questions
Does sermorelin really work?
It can stimulate the pituitary to release growth hormone. Whether that turns into higher IGF-1, more muscle, less fat, better sleep, or another result is much less certain. Small adult studies found mixed downstream outcomes.
How long does it take for sermorelin to start working?
A GH response can occur quickly. IGF-1 increased within about two weeks in one twice-daily GHRH(1-29) study but did not increase after six weeks in a once-nightly study. Body-composition changes, when reported, were measured over months.
What are the benefits of sermorelin?
The clearest benefit shown in adult research is increased GH release. Limited studies also reported selected changes in IGF-1, lean mass, body fat, skin thickness, well-being, libido, and cognition, but those results were not consistent enough to promise.
What results can I expect from sermorelin?
The studies do not support a dependable personal forecast. Modern buyers differ from the older adults studied, and outcomes varied by regimen, sex, and molecule.
Does sermorelin help you lose weight?
The reviewed trials did not show meaningful weight loss. One longer research program reported lower body fat, but body weight did not meaningfully change.
Does sermorelin build muscle?
Some research found more lean mass in older men, but lean mass is not identical to muscle and strength did not improve consistently.
Does sermorelin help with sleep?
Not reliably in the research reviewed. Sleep quality did not improve in the longer UW/VA GHRH program.
Does sermorelin increase testosterone?
There is no good evidence that it does. Sermorelin acts on the growth-hormone axis, not the hormone system that directly controls testosterone production.
Is sermorelin FDA-approved?
There is no currently marketed FDA-approved sermorelin product. Historical Geref products were FDA-approved for diagnostic and pediatric uses, then discontinued and their approvals were withdrawn. Compounded products are not FDA-approved finished drugs.
Is compounded sermorelin legal?
That question depends on the exact pharmacy, prescribing circumstances, formulation, and current federal and state compounding rules. FDA's 503A and 503B frameworks limit the use of bulk drug substances and change over time. A provider should be able to identify the dispensing pharmacy and the lawful basis for the prescription and compounding pathway.
What are the side effects of sermorelin?
Historical product experience and older studies reported injection-site reactions, flushing, headache, dizziness, and nausea. Today's compounded products do not have a current FDA-approved label establishing a standardized adult safety profile for wellness or anti-aging use.
Do sermorelin tablets or troches work?
We did not find a human clinical trial establishing patient outcomes for sermorelin tablets or troches. Injection evidence cannot be assumed to prove that an oral or buccal form works the same way.
Is sermorelin better than HGH?
They are different products with different evidence and regulatory status. FDA-approved somatropin is used for defined medical indications such as adult GH deficiency; sermorelin is not an FDA-approved anti-aging substitute.
Does sermorelin work for women?
The adult data are too limited to make a broad prediction. In the small Khorram modified-analog trial, some outcomes differed by sex, and the UW/VA program reported a weaker IGF-1 response in women taking oral estrogen.
What happens when you stop sermorelin?
The adult evidence reviewed here does not establish how long any clinical benefit lasts after stopping. A short-acting GHRH signal stops when treatment stops, but that is not the same as knowing how body-composition or symptom changes behave afterward.
How do I know if sermorelin is working for me?
Define the outcome with your clinician before treatment and use the same measurement at follow-up. A change in IGF-1 can show a hormone change, but it does not by itself prove improved sleep, body composition, strength, health, or longevity.
Is sermorelin worth the money?
Only if the reason for using it, the expected outcome, the follow-up plan, and the complete cost make sense after you understand the evidence gaps. It is a weak choice when the goal is fast weight loss, dramatic muscle gain, guaranteed sleep improvement, or treatment of low testosterone.
Still not sure which TRT care route fits you?
Use our free Find My TRT Path tool. It helps organize your goals and questions so you can see whether the next conversation belongs with testosterone evaluation, primary care, sleep care, endocrinology, reproductive urology, or another care route.
It is educational. It does not diagnose low testosterone, determine treatment eligibility, clear contraindications, guarantee a prescription, or replace a clinician.
Related guides
- Sermorelin vs TRT
- Sermorelin cost
- Where to get sermorelin online
- Sermorelin tablets vs injections
- Sermorelin side effects
- Two low testosterone tests before TRT
- What testosterone level qualifies for TRT
- How We Review TRT Providers
- Affiliate Disclosure
- Corrections Policy
This page is educational information, not medical advice. It does not diagnose any condition, interpret your personal lab results, recommend a dose, or tell you to start, stop, or change treatment. Seek urgent or emergency care for chest pain, trouble breathing, fainting, a severe allergic reaction, or another serious or rapidly worsening symptom.
Sources
- Thorner MO et al., Geref International Study Group. Once daily subcutaneous GHRH therapy accelerates growth in growth hormone-deficient children during the first year of therapy. J Clin Endocrinol Metab. 1996.
- Corpas E et al. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 1992;75(2):530-535. https://pubmed.ncbi.nlm.nih.gov/1379256/
- Vittone J et al. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism. 1997;46(1):89-96. https://pubmed.ncbi.nlm.nih.gov/9005976/
- Khorram O, Laughlin GA, Yen SSC. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. J Clin Endocrinol Metab. 1997;82(5):1472-1479. https://pubmed.ncbi.nlm.nih.gov/9141536/
- Merriam GR et al. Growth Hormone Releasing Hormone Treatment in Normal Aging. Journal of Anti-Aging Medicine. 2001;4(4):331-343. https://doi.org/10.1089/10945450152850650
- Merriam GR, Schwartz RS, Vitiello MV. Growth hormone-releasing hormone and growth hormone secretagogues in normal aging. Endocrine. 2003;22(1):41-48. https://pubmed.ncbi.nlm.nih.gov/14610297/
- U.S. Food and Drug Administration. GEREF (sermorelin acetate) approval records, NDA 19-863 and NDA 20-443; orphan-drug approval record. https://www.accessdata.fda.gov/
- U.S. Food and Drug Administration. Determination that GEREF (sermorelin acetate) injection was not withdrawn from sale for reasons of safety or effectiveness. Federal Register. March 4, 2013. https://public-inspection.federalregister.gov/2013-04827.pdf
- U.S. Food and Drug Administration. Bulk Drug Substances Used in Compounding. Current FDA 503A/503B framework. https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding
- Endocrine Society. Hormones and Aging: An Endocrine Society Scientific Statement. 2023. https://www.endocrine.org/advancing-research/scientific-statements/other-endocrine-topics/hormones-and-aging
- Endocrine Society. Hormone Replacement in Hypopituitarism Guideline Resources. Adult GH deficiency diagnostic guidance. https://www.endocrine.org/clinical-practice-guidelines/hormone-replacement-in-hypopituitarism
- Endocrine Society. Testosterone Therapy for Hypogonadism Guideline Resources; 2026 Statement on Testosterone Replacement Therapy. https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy
- World Anti-Doping Agency. 2026 Prohibited List, S2.2.4 Growth hormone releasing factors. https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf
- Liu H et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med. 2007.
- TRT Provider Guide. Affiliate Disclosure. Effective September 1, 2026. /affiliate-disclosure/
- SermorelinReport. How long does sermorelin take to work? Seller-page audit, September 2026.